Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike

There are no approved target therapeutics against SARS-CoV-2 or other beta-CoVs. The beta-CoV Spike protein is a promising target considering the critical role in viral infection and pathogenesis and its surface exposed features. We performed a structure-based strategy targeting highly conserved dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Trigueiro-Louro, João, Correia, Vanessa, Figueiredo-Nunes, Inês, Gíria, Marta, Rebelo-de-Andrade, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452956/
https://www.ncbi.nlm.nih.gov/pubmed/32913581
http://dx.doi.org/10.1016/j.csbj.2020.07.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452956/
https://www.ncbi.nlm.nih.gov/pubmed/32913581
http://dx.doi.org/10.1016/j.csbj.2020.07.017

Ejemplares similares